Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey.

Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, Burghoffer B, Noel D, Barbut F; ICD-Raisin Working Group.

Med Mal Infect. 2013 Feb;43(2):67-74. doi: 10.1016/j.medmal.2013.01.004. Epub 2013 Mar 14.

PMID:
23498135
2.

Contamination of ready-to-eat raw vegetables with Clostridium difficile in France.

Eckert C, Burghoffer B, Barbut F.

J Med Microbiol. 2013 Sep;62(Pt 9):1435-8. doi: 10.1099/jmm.0.056358-0. Epub 2013 Feb 28.

PMID:
23449876
3.

Evaluation of the chromogenic agar chromID C. difficile.

Eckert C, Burghoffer B, Lalande V, Barbut F.

J Clin Microbiol. 2013 Mar;51(3):1002-4. doi: 10.1128/JCM.02601-12. Epub 2012 Dec 26.

4.

Comparison of a commercially available repetitive-element PCR system (DiversiLab) with PCR ribotyping for typing of clostridium difficile strains.

Eckert C, Van Broeck J, Spigaglia P, Burghoffer B, Delmée M, Mastrantonio P, Barbut F.

J Clin Microbiol. 2011 Sep;49(9):3352-4. doi: 10.1128/JCM.00324-11. Epub 2011 Jul 20.

5.

Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.

Barbut F, Monot M, Rousseau A, Cavelot S, Simon T, Burghoffer B, Lalande V, Tankovic J, Petit JC, Dupuy B, Eckert C.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1279-85. doi: 10.1007/s10096-011-1224-z. Epub 2011 Apr 13.

6.

Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR.

Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C.

J Clin Microbiol. 2009 Apr;47(4):1276-7. doi: 10.1128/JCM.00309-09. Epub 2009 Feb 25. No abstract available.

7.

Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.

Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.

Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):530-5. doi: 10.1016/j.patbio.2008.09.001. Epub 2008 Oct 31.

PMID:
18977099
8.

Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.

Barbut F, Gariazzo B, Bonné L, Lalande V, Burghoffer B, Luiuz R, Petit JC.

Infect Control Hosp Epidemiol. 2007 Feb;28(2):131-9. Epub 2007 Jan 24.

PMID:
17265393
9.

Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui.

Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Ben Redjeb S, Bercion R, Gautier V, Arlet G.

Antimicrob Agents Chemother. 2006 Jul;50(7):2433-8.

10.

First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital.

Kassis-Chikhani N, Decré D, Gautier V, Burghoffer B, Saliba F, Mathieu D, Samuel D, Castaing D, Petit JC, Dussaix E, Arlet G.

J Antimicrob Chemother. 2006 Jan;57(1):142-5. Epub 2005 Nov 10.

PMID:
16284103
11.

In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.

Bidet P, Burghoffer B, Gautier V, Brahimi N, Mariani-Kurkdjian P, El-Ghoneimi A, Bingen E, Arlet G.

Antimicrob Agents Chemother. 2005 Aug;49(8):3562-5.

12.

Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains.

Barbut F, Decré D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC.

J Med Microbiol. 2005 Feb;54(Pt 2):181-5.

PMID:
15673514
13.
14.

Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.

Gonçalves C, Decré D, Barbut F, Burghoffer B, Petit JC.

J Clin Microbiol. 2004 May;42(5):1933-9.

15.

Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area.

Decré D, Verdet C, Raskine L, Blanchard H, Burghoffer B, Philippon A, Sanson-Le-Pors MJ, Petit JC, Arlet G.

J Antimicrob Chemother. 2002 Nov;50(5):681-8.

PMID:
12407124
16.

gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile.

Dridi L, Tankovic J, Burghoffer B, Barbut F, Petit JC.

Antimicrob Agents Chemother. 2002 Nov;46(11):3418-21.

17.

Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E, Petit JC.

J Clin Microbiol. 2002 Jun;40(6):2079-83.

18.

Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases.

Barbut F, Lalande V, Daprey G, Cohen P, Marle N, Burghoffer B, Petit JC.

Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):481-4.

PMID:
10947228
19.

Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile.

Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC.

J Clin Microbiol. 2000 Jul;38(7):2484-7.

20.

Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC.

J Clin Microbiol. 2000 Jun;38(6):2386-8.

21.

Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.

Barbut F, Decré D, Burghoffer B, Lesage D, Delisle F, Lalande V, Delmée M, Avesani V, Sano N, Coudert C, Petit JC.

Antimicrob Agents Chemother. 1999 Nov;43(11):2607-11.

22.

Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC.

FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6.

23.

Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.

Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, Roudot-Thoraval F.

Blood. 1997 Aug 1;90(3):1133-40.

24.

Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodies.

Lefrère JJ, Roudot-Thoraval F, Vittecoq D, Heshmati F, Audat F, Lerable J, Reed D, Petit JC, Burghoffer B, Morand-Joubert L.

Transfusion. 1996 Aug;36(8):734-8.

PMID:
8780670
25.

Comparison of two techniques for measurement of in vitro killing kinetics of five antibiotics against Pseudomonas aeruginosa.

Lesage D, Delisle F, Richard G, Burghoffer B, Le Cunff D, Petit JC.

Eur J Clin Microbiol Infect Dis. 1994 May;13(5):412-7.

PMID:
8070456
26.

Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci.

Barakett V, Lesage D, Delisle F, Burghoffer B, Richard G, Vergez P, Petit JC.

J Antimicrob Chemother. 1993 Jan;31(1):105-9.

PMID:
8444654
27.

[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].

Barakett V, Lesage D, Delisle F, Guidet B, Burghoffer B, Richard G, Offenstadt G, Vergez P, Petit JC.

Pathol Biol (Paris). 1992 May;40(5):483-91. French.

PMID:
1495831
28.

Kinetics of interleukin-1 production by macrophages during infection with Listeria monocytogenes.

Petit JC, Burghoffer B, Richard G, Daguet GL.

Int J Immunopharmacol. 1988;10(7):875-8.

PMID:
3266201
29.

Effect of imipenem (N-formimidoyl-thienamycin) on the in-vitro lymphocyte proliferation.

Petit JC, Burghoffer B, Richard G, Daguet GL.

J Antimicrob Chemother. 1987 Dec;20(6):871-4.

PMID:
3481628
30.

Influence of ciprofloxacin and piperacillin on interleukin-1 production by murine macrophages.

Petit JC, Daguet GL, Richard G, Burghoffer B.

J Antimicrob Chemother. 1987 Oct;20(4):615-7. No abstract available.

PMID:
3500165
31.
32.

Supplemental Content

Loading ...
Support Center